Researchers Discover Unexpected Cellular Response to Paclitaxel Cancer Drug

A research team at the Cancer Research Center has discovered that paclitaxel, one of the most widely used chemotherapy drugs for treating solid tumors, triggers an unexpected cellular response beyond its known mechanism. The study reveals that paclitaxel causes rapid contraction of cancer cells in addition to its established ability to interfere with cell division. This discovery could provide new insights into how the drug works and potentially lead to improved cancer treatment strategies. The findings may help oncologists better understand paclitaxel's effectiveness against various solid tumors and optimize its therapeutic use in patients.